BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang HM, Li FP, Zhang HY, Liu XR, Chen XH, Liang HY, Yan X, Xie Q, Zhong R, Lai M, Zhong XF, Liu H, Zhao LY. High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer. World J Gastroenterol 2026; 32(8): 115333 [PMID: 41809879 DOI: 10.3748/wjg.v32.i8.115333]
URL: https://www.wjgnet.com/1007-9327/full/v32/i8/115333.htm
Number Citing Articles
1
Hou-Shu Tu, Meng-Lin Chen, Jing Hong, Sai Li, Ling He. Stage-aware programmed death ligand 1 assessment in gastric cancer: Implications for perioperative immunotherapyWorld Journal of Gastroenterology 2026; 32(33): 118672 doi: 10.3748/wjg.118672
2
Koji Takahashi. Stage-dependent prognostic value of programmed death ligand-1 expression in gastric cancer: Implications for personalized immunotherapyWorld Journal of Gastroenterology 2026; 32(34): 118762 doi: 10.3748/wjg.118762